Extreme thrombocytosis is associated with critical illness and young age, but not increased thrombotic risk, in hospitalized pediatric patients.
Christopher Stephen ThomEmily EchevarriaAshley D OsborneLeah CarrKathryn M RubeyElizabeth SalazarDanielle CallawayThomas PawlowskiMatthew DevineStacey KleinmanChar WitmerJohn FlibotteMichele P LambertPublished in: Journal of thrombosis and haemostasis : JTH (2020)
Our findings confirm that thrombotic events related to EXT are rare in pediatric patients, which can inform the use of empiric anti-platelet therapy.